Ameriprise
CPXX

Ameriprise’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Ameriprise’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-42,800
Closed -$1.29M – 3929
2016
Q2 		$1.29M Buy
+42,800
New +$868K ﹤0.01% 2764

Ameriprise's CPXX Position: Q3 2016 in Review

Ameriprise sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 59,227 shares — an estimated $1.79M sold.

Ameriprise first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $2.04M in Q1 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Ameriprise reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Ameriprise sold 59,227 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.79M.
  • Ameriprise first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
  • Ameriprise's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $2.04M in Q1 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Ameriprise's 13F filing for Q3 2016, filed 8 Nov 2016.